日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology

贝叶斯中期分析在血液肿瘤学随机II期和III期临床试验中的附加价值

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.288675
Smit, Anna J T; Van der Maas, Niek G; Van der Holt, Bronno; Van Norden, Yvette; Van Werkhoven, Erik; Vangsted, Annette Juul; Ypma, Paula F; Visser-Wisselaar, Heleen A; Troia, Rossella; Boccadoro, Mario; Löwenberg, Bob; Janssen, Jeroen J W M; Ossenkoppele, Gert J; Schjesvold, Fredrik; Sonneveld, Pieter; Zweegman, Sonja; Versluis, Jurjen; Cornelissen, Jan J
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Hemostatic and platelet proteins are associated with bleeding grade and time to major bleed in hemato-oncological patients

血液肿瘤患者的止血蛋白和血小板蛋白与出血程度和发生大出血的时间相关。

期刊:
影响因子:
doi:10.1016/j.bvth.2026.100144
Muñoz Sandoval, Diana; Smit, Eva R; Rojas-Rodriguez, Felipe; van der Meer, Pieter F; Voorberg, Jan; van der Zwaan, Carmen; Langerhorst, Pieter; Hoogendijk, Arie J; van Dam, Teunis J P; Kerkhoffs, Jean-Louis; Ypma, Paula F; van den Biggelaar, Maartje
血小板
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome

揭示极度虚弱的患者群体：多发性骨髓瘤新诊断患者中一个独特的亚组，该亚组患者不适合接受移植，且临床预后较差。

期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70268
Groen, Kazimierz; Smits, Febe; Nasserinejad, Kazem; Levin, Mark-David; Regelink, Josien C; Timmers, Gert-Jan; de Waal, Esther G M; Westerman, Matthijs; Velders, Gerjo A; de Heer, Koen; Leys, Rineke B L; van Kampen, Roel J W; Stege, Claudia A M; Seefat, Maarten R; Nijhof, Inger S; van der Spek, Ellen; Klein, Saskia K; van de Donk, Niels W C J; Ypma, Paula F; Zweegman, Sonja
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial

随机临床试验中的适应性设计：HOVON87/NMSG18 多发性骨髓瘤试验的重新分析

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103605
Seefat, Maarten R; van der Maas, Niek G; Nasserinejad, Kazem; van der Holt, Bronno; Waage, Anders; Mellqvist, Ulf-Henrik; Vangsted, Annette Juul; Smit, Anna J T; Smits, Febe; Ypma, Paula F; van de Donk, Niels W C J; Blommestein, Hedwig M; Cornelissen, Jan J; Cucchi, David G J; Zweegman, Sonja; Versluis, Jurjen
多发性骨髓瘤
多发性硬化症
骨髓瘤
发表日期：2025
文献求助 收藏

Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study

口服布鲁顿酪氨酸激酶抑制剂利扎替尼治疗免疫性血小板减少症患者的疗效和安全性结果：II期B部分研究

期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.27539
Cooper, Nichola; Jansen, A J Gerard; Bird, Robert; Mayer, Jiří; Sholzberg, Michelle; Tarantino, Michael D; Garg, Mamta; Ypma, Paula F; McDonald, Vickie; Percy, Charles; Košťál, Milan; Goncalves, Isaac; Bogdanov, Lachezar H; Gernsheimer, Terry B; Diab, Remco; Yao, Mengjie; Daak, Ahmed; Kuter, David J
血小板
信号转导
免疫/内分泌
发表日期：2025
文献求助 收藏

Sexuality and bleeding in von Willebrand disease

血管性血友病患者的性功能和出血情况

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2025.102712
van Kwawegen, Calvin B; Pastoor, Hester; Eikenboom, Jeroen; Fijnvandraat, Karin; Ypma, Paula; Heubel-Moenen, Floor C J I; van Galen, Karin P M; Mauser-Bunschoten, Evelien P; Meijer, Karina; Schols, Saskia E M; Cnossen, Marjon H; van der Bom, Johanna G; de Meris, Joke; Atiq, Ferdows; Kruip, Marieke J H A; Leebeek, Frank W G
发表日期：2025
文献求助 收藏

Impact of platelet transfusions on plasma proteomes in controlled endotoxemia and in hemato-oncological patients

血小板输注对控制性内毒素血症和血液肿瘤患者血浆蛋白质组的影响

期刊:Transfusion
影响因子:2
doi:10.1111/trf.18397
Smit, Eva R; Viegen, Isabella; van der Meer, Pieter F; van Wonderen, Stefan F; van Baarle, Floor L F; Ypma, Paula F; Kerkhoffs, Jean-Louis H; Voorberg, Jan; Vlaar, Alexander P J; Peters, Anna L; van den Biggelaar, Maartje; Muñoz Sandoval, Diana
血小板
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Field data on sea ice restoration by artificial flooding in subarctic Canada

加拿大亚北极地区人工洪水恢复海冰的实地数据

期刊:Data in Brief
影响因子:1.4
doi:10.1016/j.dib.2025.112147
Owen, Cody C; Afzali, Soroosh; Schellingerhout, Willem; Meijeraan, Tom; Ypma, Fonger
发表日期：2025
文献求助 收藏

Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial

在接受大剂量硼替佐米治疗且符合移植条件的初诊多发性骨髓瘤患者中，接受硼替佐米治疗前后的疗效：来自 III 期 HOVON-65/GMMG-HD4 试验的 10 年以上随访后的长期总生存期

期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70052
Mai, Elias K; Nogai, Axel; Lokhorst, Henk M; van der Holt, Bronno; Zweegman, Sonja; Weisel, Katja C; Croockewit, Sandra; Jauch, Anna; Hillengass, Jens; Stevens-Kroef, Marian; Raab, Marc S; Broijl, Annemiek; Bos, Gerard M J; Brossart, Peter; Ypma, Paula; Hanoun, Christine; Bertsch, Uta; Hielscher, Thomas; Salwender, Hans J; Scheid, Christoph; Goldschmidt, Hartmut; Sonneveld, Pieter
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes

评估多发性骨髓瘤患者的虚弱程度：追求简便性可能会牺牲预测临床结果的精确性

期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.85
Groen, Kazimierz; Smits, Febe; Nasserinejad, Kazem; Levin, Mark-David; Regelink, Josien C; Timmers, Gert-Jan; de Waal, Esther G M; Westerman, Matthijs; Velders, Gerjo A; de Heer, Koen; Leys, Rineke B L; van Kampen, Roel J W; Stege, Claudia A M; Seefat, Maarten R; Nijhof, Inger S; van der Spek, Ellen; Klein, Saskia K; van de Donk, Niels W C J; Ypma, Paula F; Zweegman, Sonja
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏